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ABSTRACT
Behcet’s disease (BD) is a multi-system recurrent inflammatory disorder occurring in the form of vasculitis of an
unknown etiology. It most frequently affects oral and genital mucosa, skin, eyes, joints, and blood vessels. The
definitive diagnosis of BD is based on major symptoms such as recurrent oral and genital ulcers and recurrent skin
and ocular lesions, accompanied by symptoms related to various systems. However, early BD manifestations are
very similar to recurrent aphthous stomatitis (RAS). Several years from its first appearance are often required for a
definitive diagnosis. Objective: To describe a dentist’s role in BD management in a patient with a history of highly
recurrent RAS. Case Report: We evaluated a 38-year-old man with a 10-year history of recurrent oral ulcers,
accompanied by skin and eyes lesions. His intraoral examination revealed multi-sized ulcers with a yellowishwhite base and regular edges, surrounded by an erythematous halo. Ulcers were located on the tongue, floor of the
mouth, and gingival mucosa. Although BD diagnosis was not histopathologically confirmed, the patient’s lesions
met the International Criteria for Behcet’s disease with a score of 5. Oral ulcers were managed with chlorhexidine
mouthwash 2 times/day and supportive measures. A multidisciplinary approach was used for this patient to provide
comprehensive treatment. Conclusion: Dentists can be the first clinicians to detect the possible development of BD
in patients with symptoms similar to RAS, but additionally having skin and eye lesions.
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INTRODUCTION
Behcet’s disease (BD) is a multi-system recurrent
inflammatory disorder characterized by the development
of vasculitis of an unknown etiology.1–3 BD affects
almost all systems, including the vascular, central
nervous, gastrointestinal, pulmonary, and urologic
systems and the joints. The disease is characterized
by four major symptoms: oral aphthous ulcers, genital
ulcers, skin lesions, and ocular lesions. Additionally,
one or more minor symptoms can be observed, including
arthritis, gastrointestinal ulceration, epididymitis,
vascular lesions, and symptoms involving the central
nervous system.3–5
In 1937, HÛlusi Behcet, a Turkish dermatologist,
was the first to comprehensively describe a triad of
symptoms including recurrent oral ulcers, genital

ulcers, and uveitis, which were subsequently labeled
as Behcet’s syndrome.3,4 BD prevalence is related to an
ancient trade route known as the “Silk Road.” BD occurs
worldwide with marked regional differences. Its highest
incidence has been observed in the Mediterranean
regions, Middle East, and Far East (Table 1).3,6–8
The age at onset ranges between 20 and 40. BD more
frequently and severely affects males. The male-tofemale ratio differs among countries. Specifically,
females are more commonly affected in Japan and
Korea, whereas males are more commonly affected in
the Middle East region. Severe manifestations such as
uveitis and neurological and vascular involvement are
predominantly observed in males.2,7,8 Behcet’s disease
is a recurrent multisystem vasculitis that can affect
any organ or system, but was originally described as
orogenital ulcerations and uveitis. Specific criteria
have been proposed for diagnosis and identification
125
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Table 1. Worldwide Prevalence of Behcet’s Disease
Country

Prevalence
Per 100,000

Turkey
Saudi Arabia
Iraq
Iran
Japan
Egypt
Hong Kong
Taiwan
The United States
European countries

20–421
19.5
17
16.7–80
14,6
7.6
2.6
1
0.33
0.27–7.5

of affected organs by different national authorities.
Behcet’s disease is proposed to be due to an antigen/
antibody reaction. The antigen can be external
(microbial or other

Figure 1. Regular ulcer on the left lateral of tongue region 34
and 37 (a), on the right lateral of tongue region 47(b), on the
border gingival lingual and floor of the mouth region 32 (c).

Recurrent aphthous stomatitis (RAS) is a disorder
characterized by recurrent ulcers confined to the
oral mucosa in patients otherwise asymptomatic.9
Because recurring oral ulcers are found in BD and
RAS, the latter is considered during BD’s differential
diagnosis. Histopathological examination is necessary
for a clinical distinction.4,5,10 RAS is the most frequent
chronic disease of the oral cavity, affecting 5%–25% of
the population. It more frequently affects females and
individuals of higher socioeconomic levels.11 The age at
onset ranges between 10 and 40 years. BD’s definitive
diagnosis relies on the presence of major symptoms,
occasionally accompanied by minor symptoms.4,5,11
We report the case of patient with a 10-year history
of RAS who then developed skin lesions and eyes
symptoms, changing the diagnosis to BD.

CASE REPORT
A 38-year-old male was referred from the Internal
Medicine Department for an oral biopsy to identify
vasculitis for potential BD diagnosis. He had a 10-year
history of RAS (feverless) and later developed skin
and eye lesions. These ulcers were painful and selfhealed in 3–4 weeks. Ulcer-free intervals lasted about
2 weeks. As per a dentist’s prescription, the patient took
triamcinolon acetonide and nystatin oral suspension. In
the previous 2 years, the patient suffered from pullulent
and painful vesicles of both the thighs. No genital
ulcers were reported, whereas itchiness and soreness
were present.
A recent complaint of red eyes and blurred vision was
diagnosed as uveitis. As a differential diagnosis, an
internist requested screening for human immunodeficiency virus (HIV), venereal disease research laboratory (VDRL), Treponema pallidum hemagglutination
assay (TPHA), toxoplasma, rubella, cytomegalovirus,

Figure 2. Second visit 2 weeks later, healing of ulcer on the
right lateral of tongue (a), on the left lateral of a

and herpes simplex virus (TORCH), and anti-nuclear
antibody (ANA). Blood tests showed a low count of
leukocytes, basophils, lymphocytes, and neutrophils,
with a high erythrocyte sedimentation rate. HIV, VDRL,
and TPHA screenings were non-reactive. TORCH
examination revealed reactive anti-toxoplasma IgG,
anti-cytomegalovirus IgG, and anti-HSV II IgG. ANA
examination results were positive, with speckled pattern
and a titer of 1/100. A pathergy test was negative, and
mycological examination showed absence of fungal
infections.
An intraoral examination revealed fair oral hygiene;
subgingival and supragingival calculus; and ulcers 2–5
mm in diameter, surrounded by an erythematous halo
and yellowish-white base, located at the border between
126
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Table 2. International Study Group criteria for the Diagnosis
of Behcet’s Disease

Table 3. Criteria for The Diagnosis of Behcet’s Disease.
Sign/symptom

Recurrent
oral
ulceration

Minor/major aphthous or herpetiform
ulcer that recurred at least 3 times in
a 12-month period observed by the
physician or patient
Plus two of the following:
Recurrent
genital
ulceration
Eye lesions

Aphthous ulcer or scarring observed by
the physician or patient

Cutaneous
lesions

Anterior/posterior uveitis, cells in
the vitreous on slit-lamp examination
or retinal vasculitis observed by
anophthalmologist
Erythema nodosum observed by
physician or patient, pseudofolliculitis
or papulopustular lesions, or acneiform
nodules observed by physician in
postadolescent patients not receiving
corticosteroids

Positive
pathergy test

Interpreted by the physician at 24–48 h

the gingival and floor of the mouth in the region 32
and in the lateral tongue in the regions 47, 37, and 34
(Figure 1). History and clinical examination provided
a working diagnosis of oral manifestations of BD and
chronic gingivitis. A biopsy of an ulcer on the left lateral
tongue was performed. Oral ulcers were treated with
mouthwash containing 0.2% chlorhexidine 2 times/day.
The biopsy revealed chronic ulcers, without any
evidence of malignancy and vasculitis, thus not
confirming BD’s diagnosis. Oral examination revealed
healing ulcers, with traumatic laceration on the left
palate in the region 28 following oral treatment
during biopsy (Figure 2). The medications included
prednisolone, azathioprine, omeprazole, folic acid, and
prednisolone eye drops (for 1 week). The oral diagnosis
was based on BD’s oral manifestations, traumatic ulcers,
and chronic gingivitis. Oral ulcers were treated using
moistened gauze compresses with 0.2% chlorhexidine
3 times/day and supportive multivitamins containing
vitamin B complex, vitamin C, vitamin E, folic acid
and zinc, once a day.

DISCUSSION
BD manifestations are variable, depending on ethnic,
geographic, and individual differences. Manifestations
range from mucocutaneous and eye symptoms to
systemic involvement with serious complications.
The criteria for BD diagnosis were outlined by the
International Study Group in 1990 (Table 2).4,8,12
However, application of these criteria in daily practice
is very difficult. Moreover, because organs are not
involved, it is less sensitive. Meanwhile, several studies

Ocular lesions
Genital aphthosis
Oral aphthosis
Skin lesions
Neurological manifestations
Vascular manifestations
Positive pathergy test

Points
2
2
2
1
1
1
1

International Criteria for Behcet’s Disease: scoring ≥4
indicates Behcet’s disease

have reported that use of a positive pathergy test has
decreased since the mid-1980s. The International
Team for the Revision of the International Criteria
for Behcet’s Disease (ICBD) has recently proposed a
new set of criteria, including neurological, vascular,
mucocutaneous, and ocular manifestations, where
a pathergy test is included, but not in the primary
scoring criteria. A 2014 draft revision also included
minor symptoms (i.e., neurological and vascular
manifestations), whereas the pathergy test and
HLA-B51 were considered as supportive examinations
(Table 3).8,13
BD pathogenesis showed a prominent role of T
lymphocytes, hyperactive neutrophils, and elevated
levels of pro-inflammatory cytokines IL-8, IL-17,
and TNF-α. These factors stimulate adhesion of
molecules on vascular endothelial cells including
CD54 (intercellular adhesion molecule-1 [ICAM1]), vascular adhesion molecule 1 (VCAM-1), and
E-selectin by human dermal microvascular endothelial
cells. Neutrophil infiltration in the perivascular causes
vasculitis.9,14 HSV infection was suggested as a possible
etiologic or triggering factor in BD. In a study by Lee et
al., HSV type 1 was detected using PCR in the saliva,
intestinal ulcers, and genital ulcers of BD patients
(absent in healthy controls), and HSV induced the
production of various cell adhesion molecules.15
A Japanese study on 412 patients showed that oral
aphthae were the most frequent initial symptom,
appearing in average 7.2 ± 10.2 years before BD
diagnosis. Genital ulcers and skin and eye lesions
appeared as the initial symptoms in approximately 25%
patients. Conversely, gastrointestinal, neurological, and
vascular complications developed post-diagnosis.8 Oral
aphthous as initial BD symptoms was found in 96.4%
of patients in Iran, 98.2% in Japan, 100% in Turkey,
97.5% in Korea, 100% in Morocco, and 100% in UK.
Oral ulcers are usually located on the tongue (79.6%),
lips (79.1%), buccal cavity (73.7%), gingiva (59.5%),
and, occasionally, tonsils (29.5 %), palate (27.5%),
pharynx (25.3%), larynx, and esophagus. Interval
between recurrences varies from several days to several
months.14,16
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Table 4. Classification of Recurrent Aphthous Stomatitis
(Roy S. Rogers)
Simple Aphthosis
Common
Episodic
Short-lived lesion
Few lesions
3–6 episodes/year
Prompt healing
Minimal pain
Limited to oral cavity

Complex Aphthosis
Uncommon
Episodic or continuous
Persistent
Few to many lesions
Frequent or continuous
ulceration
Slow healing
Marked pain
May have genital lesions

Recurrent oral ulcers in BD are critical for diagnosis;
however a distinction from RAS is difficult. Roy S.
Rogers classified oral aphthous into simple and complex
aphthosis (Table 4). BD patients usually have complex
aphthosis. Simple aphthosis is the most common with
episodic and short-lived lesions, typically occurring in
younger individuals (20%–50%). Complex aphthosis is
rare, persistent, and associated with chronic systemic
diseases.17 Major ulcers (diameter >10 mm) are linked
to the highest risk of BD, whereas minor ulcers
(diameter <10 mm) to the lowest risk. Compared
with RAS patients, BD patients develop oral ulcers
at ≥2 locations. RAS patients with complex aphthosis
require monitoring using BD clinical criteria due to
the possibility of developing BD. The mortality and
morbidity rates in BD are based on the involvement of
the gastrointestinal tract and vascular or central nervous
systems. Such conditions may cause life-threatening
complications including bowel perforation, arterial
occlusion, and outbreak aneurisma.3,4
In this report, oral ulcers were characterized by similar
features among each other. Specifically, they were minor
aphthous, with a yellowish-white base and surrounded
by an erythematous halo and well-circumscribed and
round ulcers. These ulcers self-healed and spread
to different sites of the oral cavity. Tursen found
that histopathological examination of oral ulcers in
BD showed nonspecific pathological findings, with
lymphocytic vasculitis identified in severe ulcerations.18
In the present study, BD diagnosis was not confirmed
by histopathological examination possibly due to the
ulcers’ healing process. However, the patient’s lesions
(oral, eye, and skin lesions) met the ICBD guidelines
with a score of 5.
Till date, there is no specific diagnostic laboratory test or
histopathological finding for BD. A definitive diagnosis
relies on clinical features that requires several years.
Patients with exclusively recurrent oral ulcers may not
obtain a definitive diagnosis for BD; therefore, these
patients require in-depth examination and accurate
follow-up, particularly in countries with a high BD
prevalence.16

CONCLUSION
Dentists’ role is important in establishing BD
diagnosis; they could be the first to detect the disease.
Recurrent oral ulcers are a common initial symptom
of BD, accompanied by skin and eye lesions. A
multidisciplinary approach is required to diagnose and
treat the disease.
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